Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2728 results

Sort By:

Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE)

Study ID: NCT07169799
Start Date: 2026-09-22
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

trūFreeze® Spray Cryotherapy System (STERIS Endoscopy)

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Improving Adherence to COPD Treatments in Primary Care

Study ID: NCT07104136
Start Date: 2025-11-15
End Date: 2027-05-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

COPD-care seminar

Sponsor

Tel-Aviv Sourasky Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Impact of Facility Dog Intervention on Pediatric Patients

Study ID: NCT07221006
Start Date: 2025-12-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

126

Intervention / Treatment

Coloring page activity led by CLAC

Mindfulness Activity led by CCLS

Mindfulness Activity led by CCLS and Facility Dog

Sponsor

Children's Hospital Colorado

Source: clinicaltrials.gov

Share:
Add to list

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Study ID: NCT06890338
Start Date: 2025-11-24
End Date: 2030-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

140

Intervention / Treatment

Carboplatin

Mirvetuximab Soravtansine

bevacizumab

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

TO Plate Fixation vs. External Fixator Comparison (HTO Plate vs. ExFix Study)

Study ID: NCT07220434
Start Date: 2025-11-15
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

28

Intervention / Treatment

Medial HTO Locking Plate

Self-Adjusting HTO External Fixator

Sponsor

Muhammed Cagatay Engin

Source: clinicaltrials.gov

Share:
Add to list

Testing the Combination of Anti-cancer Drugs, Tovorafenib Plus Rituximab, in Patients With Hairy Cell Leukemia

Study ID: NCT06965114
Start Date: 2026-06-27
End Date: 2030-03-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

84

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Cladribine

Computed Tomography

Rituximab

Tovorafenib

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Subjects With Type 2 Diabetes

Study ID: NCT07223333
Start Date: 2025-12-10
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

56

Intervention / Treatment

PATAS Trifluoroacetate

Placebo

Sponsor

AdipoPharma LLC

Source: clinicaltrials.gov

Share:
Add to list

Alzheimer's Disease THErapy With NEuroaid II

Study ID: NCT07191028
Start Date: 2025-12
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase3

No. of Participants

350

Intervention / Treatment

MLC 901

Placebo

Sponsor

Moleac Pte Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Induction Agent Choice With Early Mortality and Prognostic Outcomes in Critically Ill Patients

Study ID: NCT07222007
Start Date: 2025-12-01
End Date: 2026-09-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

4

Intervention / Treatment

induction type for intubation in ICU

Sponsor

Zeliha Alicikus

Source: clinicaltrials.gov

Share:
Add to list

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

Study ID: NCT06996652
Start Date: 2026-01
End Date: 2029-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

108

Intervention / Treatment

Adalimumab

Placebo

Sponsor

Yale University

Source: clinicaltrials.gov

Share:
Add to list